Published March 6, 2026 | Version v1
Dataset Open

QURUQ KO'Z SINDROMINING EPIDEMIOLOGIYASI VA KLINIK AHAMIYATI

Authors/Creators

Description

Quruq ko‘z sindromi (QKS) — ko‘zning yuzaki namligini ta’minlaydigan plyonka barqarorligining buzilishi natijasida yuzaga keladigan ko‘p faktorli kasallik. Epidemiologik tadqiqotlar shuni ko‘rsatadiki, dunyo bo‘yicha kattalar va yoshlar orasida QKS tarqalishi ortib bormoqda [1,2]. Kasallik, ayniqsa, 50 yoshdan oshgan shaxslar orasida keng tarqalgan bo‘lib, ko‘rish sifati va hayot sifatiga sezilarli ta’sir ko‘rsatadi [3].

Files

31-32.pdf

Files (263.7 kB)

Name Size Download all
md5:0a880babeb0cf5867f3077e5ccf8a8e2
263.7 kB Preview Download

Additional details

References

  • 1.Stapleton F., Alves M., Bunya V.Y., et al. TFOS DEWS II Epidemiology Report // The Ocular Surface. – 2017. – Vol. 15. – P. 334–365.
  • 2.Craig J.P., Nichols K.K., Akpek E.K., et al. TFOS DEWS II Definition and Classification Report // The Ocular Surface. – 2017. – Vol. 15. – P. 276–283.
  • 3.Lemp M.A., Crews L.A., Bron A.J., et al. Distribution of dry eye disease in a population-based sample // Ophthalmology. – 2007. – Vol. 114. – P. 39–45.
  • 4.Schaumberg D.A., Sullivan D.A., Buring J.E., et al. Prevalence of dry eye among US women // American Journal of Ophthalmology. – 2003. – Vol. 136. – P. 318–326.
  • 5.Sullivan D.A., Rocha E.M., Aragona P., et al. Tear film instability in dry eye disease // Progress in Retinal and Eye Research. – 2012. – Vol. 31. – P. 129–151.
  • 6.Bron A.J., de Paiva C.S., Chauhan S.K., et al. TFOS DEWS II Pathophysiology Report // The Ocular Surface. – 2017. – Vol. 15. – P. 438–510.
  • 7.Nichols K.K., Foulks G.N., Bron A.J., et al. TFOS DEWS II Management and Therapy Report // The Ocular Surface. – 2017. – Vol. 15. – P. 559–628.
  • 8.Uchino M., Schaumberg D.A. Dry eye disease: impact on quality of life and vision // Current Opinion in Ophthalmology. – 2013. – Vol. 24. – P. 319–324.
  • 9.Miljanović B., Dana R., Sullivan D.A., et al. Impact of dry eye syndrome on vision-related quality of life // American Journal of Ophthalmology. – 2007. – Vol. 143. – P. 409–415.
  • 10.McMonnies C.W. Mechanisms, pathophysiology and epidemiology of dry eye // Clinical & Experimental Optometry. – 2007. – Vol. 90. – P. 400–412.
  • 11.Vehof J., Snieder H., Jansonius N.M., et al. Risk factors for dry eye syndrome: genetic and environmental influences // Ophthalmology. – 2010. – Vol. 117. – P. 1237–1243.
  • 12.Chia E.M., Mitchell P., Rochtchina E., et al. Age-related changes in dry eye prevalence // Ophthalmology. – 2003. – Vol. 110. – P. 659–664.
  • 13.Milner M.S., Beckman K.A., Luchs J.I., et al. Dry eye disease: pathophysiology and management // Journal of Clinical Medicine. – 2017. – Vol. 6. – P. 60–74.
  • 14.Baudouin C., Aragona P., Messmer E.M., et al. Role of inflammation in dry eye disease // Ophthalmology. – 2014. – Vol. 121. – P. 125–133.